Publications by authors named "Zachary D Crees"

Claim this Profile
A
A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate E-Selectin Inhibition with Uproleselan to Reduce Gastrointestinal Toxicity During Autologous Hematopoietic Cell Transplantation for Multiple Myeloma.
Zachary D Crees, Keith Stockerl-Goldstein, Meaghan Ryan, Feng Gao, Brandon Christen

Transplant Cell Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase Ib trial of isatuximab, bendamustine, and prednisone in relapsed/refractory multiple myeloma.
Scott R Goldsmith, Michael J Slade, Mark Fiala, Melinda Harding, Zachary D Crees

Ann Hematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024.
John A Thompson, Bryan J Schneider, Julie Brahmer, Mohammad Abu Zaid, Amaka Achufusi, Zachary D Crees

J Natl Compr Canc Netw· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical whole-genome sequencing and FISH identify two different fusion partners for NUP98 in a patient with acute myeloid leukemia: A case report.
Bahareh A Mojarad, Zachary D Crees, Molly C Schroeder, Zhifu Xiang, Justin Vader

Cancer Genet· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Adjuvant Therapy With Interleukin-7 in a Lymphopenic Patient With Aplastic Anemia and Mucormycosis.
Zachary D Crees, Dilan A Patel, Alexandra Dram, Miriam Kim, Michael D Bern

Crit Care Explor· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic stem cell mobilization for allogeneic stem cell transplantation by motixafortide, a novel CXCR4 inhibitor.
Zachary D Crees, Michael P Rettig, Asad Bashey, Steven M Devine, Samantha Jaglowski

Blood Adv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovations in hematopoietic stem-cell mobilization: a review of the novel CXCR4 inhibitor motixafortide.
Zachary D Crees, Michael P Rettig, John F DiPersio

Ther Adv Hematol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Simplified Score to Predict Early Relapse in Multiple Myeloma (S-ERMM) in the MMRF CoMMpass study.
Michael Slade, Mark Fiala, Sarah Kelley, Zachary D Crees, Mark A Schroeder

Leuk Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial.
Zachary D Crees, Michael P Rettig, Reyka G Jayasinghe, Keith Stockerl-Goldstein, Sarah M Larson

Nat Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 and Light Chain Amyloidosis, Adding Insult to Injury.
Zachary D Crees, Keith Stockerl-Goldstein

Am J Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular Therapy Updates in B-Cell Lymphoma: The State of the CAR-T.
Zachary D Crees, Armin Ghobadi

Cancers (Basel)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGFR/c-Met and mTOR signaling are predictors of survival in non-small cell lung cancer.
Zachary D Crees, Caleb Shearrow, Leo Lin, Jennifer Girard, Kavin Arasi

Ther Adv Med Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GENESIS: Phase III trial evaluating BL-8040 + G-CSF to mobilize hematopoietic cells for autologous transplant in myeloma.
Zachary D Crees, Keith Stockerl-Goldstein, Abi Vainstein, Hemda Chen, John F DiPersio

Future Oncol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital Ischemia and Necrosis: A Rarely Described Complication of Gemcitabine in Pancreatic Adenocarcinoma.
Eiichiro So, Zachary D Crees, Danielle Crites, Andrea Wang-Gillam

J Pancreat Cancer· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis